Search results
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 2 days agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
Maryland-based Novavax soars on big vaccine deal - WTOP News
WTOP Washington· 2 days agoGaithersburg, Maryland-based Novavax has signed a $1.2 billion licensing agreement with French...
Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 losses | Invezz
Invezz· 2 days agoNovavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the...
Novavax stock soars 40% on Sanofi partnership By Investing.com
Investing.com· 2 days agoFor the first quarter, Novavax reported a first-quarter loss per share of $1.05, wider than the...
France’s Sanofi in COVID-19 vaccine deal with Novavax
WHTC 1450 Holland· 2 days agoPARIS (Reuters) - Sanofi on Friday announced it has reached a licensing agreement with Novavax to...
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize...
Benzinga· 2 days agoSanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines ...
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with Strategic Partnerships and Cost ...
GuruFocus.com via Yahoo Finance· 2 days agoChallenges and Forward Strategy The company is not without its challenges, notably the ongoing need to manage high operational costs and navigate the complex regulatory landscape for
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with
Guru Focus· 2 days agoThe company, a prominent player in the biotechnology sector focusing on the development of vaccines, reported a net loss of $147.55 million with a loss per share of $1.05.
Novavax shares surge on new $1.4 billion deal with Sanofi
Market Watch· 2 days agoNovavax will also be entitled to a further $200 million in additional launch and sales milestone...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
FOX 4 Kansas City· 2 days agoAnnounces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop ...